Bertek Pharmaceuticals International

Bertek Pharmaceuticals International was a pharmaceutical company and a subsidiary of Mylan Laboratories. The company focused on the development, licensing, and commercialization of branded proprietary pharmaceuticals, with primary therapeutic areas including dermatology, neurology, and cardiology. Its notable product portfolio included Amnesteem (isotretinoin) for severe acne, Apokyn (apomorphine hydrochloride) for advanced Parkinson's disease, and nebivolol for hypertension. The company utilized transdermal drug delivery technologies and operated as part of Mylan's branded products division before being dissolved in 2010.